# Chemo-embolization for Head and Neck Cancer

> **NCT04595981** · PHASE2 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- SCCHN
- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT04595981
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2027-05
- **Primary completion:** 2029-05
- **Final completion:** 2030-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No staff or funding to do the study.
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595981, "Chemo-embolization for Head and Neck Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04595981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*